[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Parkinson's Disease Drug Market Research Report Forecast 2017-2021

August 2017 | 103 pages | ID: GFE4CF017ABEN
S&P Consulting

US$ 2,240.00 US$ 2,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Parkinson's Disease Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Parkinson's Disease Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Parkinson's Disease Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
Global Parkinson's Disease Drug Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical
Abbvie
Akorn
Astellas Pharma
Desitin Arzneimittel
Endo International

Global Parkinson's Disease Drug Market: Product Segment Analysis

Type 1
Type 2
Type 3


Global Parkinson's Disease Drug Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 PARKINSON'S DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Parkinson's Disease Drug Market Segmentation by Type
  1.2.1 Global Production Market Share of Parkinson's Disease Drug by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Parkinson's Disease Drug Market Segmentation by Application
  1.3.1 Parkinson's Disease Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Parkinson's Disease Drug Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Parkinson's Disease Drug (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON PARKINSON'S DISEASE DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL PARKINSON'S DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 Global Parkinson's Disease Drug Production and Share by Manufacturers (2015 and 2016)
3.2 Global Parkinson's Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Parkinson's Disease Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Parkinson's Disease Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Parkinson's Disease Drug Market Competitive Situation and Trends
  3.5.1 Parkinson's Disease Drug Market Concentration Rate
  3.5.2 Parkinson's Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL PARKINSON'S DISEASE DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Parkinson's Disease Drug Production by Region (2012-2017)
4.2 Global Parkinson's Disease Drug Production Market Share by Region (2012-2017)
4.3 Global Parkinson's Disease Drug Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL PARKINSON'S DISEASE DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Parkinson's Disease Drug Consumption by Regions (2012-2017)
5.2 North America Parkinson's Disease Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Parkinson's Disease Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Parkinson's Disease Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Parkinson's Disease Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Parkinson's Disease Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Parkinson's Disease Drug Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL PARKINSON'S DISEASE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Parkinson's Disease Drug Production and Market Share by Type (2012-2017)
6.2 Global Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
6.3 Global Parkinson's Disease Drug Price by Type (2012-2017)
6.4 Global Parkinson's Disease Drug Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL PARKINSON'S DISEASE DRUG MARKET ANALYSIS BY APPLICATION

7.1 Global Parkinson's Disease Drug Consumption and Market Share by Application (2012-2017)
7.2 Global Parkinson's Disease Drug Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL PARKINSON'S DISEASE DRUG MANUFACTURERS ANALYSIS

8.1 Boehringer Ingelheim
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 GlaxoSmithKline
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Novartis
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Teva Pharmaceutical
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Abbvie
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Akorn
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Astellas Pharma
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Desitin Arzneimittel
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Endo International
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview



CHAPTER 9 PARKINSON'S DISEASE DRUG MANUFACTURING COST ANALYSIS

9.1 Parkinson's Disease Drug Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Parkinson's Disease Drug

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Parkinson's Disease Drug Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL PARKINSON'S DISEASE DRUG MARKET FORECAST (2017-2021)

13.1 Global Parkinson's Disease Drug Production, Revenue Forecast (2017-2021)
13.2 Global Parkinson's Disease Drug Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Parkinson's Disease Drug Production Forecast by Type (2017-2021)
13.4 Global Parkinson's Disease Drug Consumption Forecast by Application (2017-2021)
13.5 Parkinson's Disease Drug Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson's Disease Drug
Figure Global Production Market Share of Parkinson's Disease Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Parkinson's Disease Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Parkinson's Disease Drug Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Parkinson's Disease Drug Capacity of Key Manufacturers (2015 and 2016)
Table Global Parkinson's Disease Drug Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Parkinson's Disease Drug Capacity of Key Manufacturers in 2015
Figure Global Parkinson's Disease Drug Capacity of Key Manufacturers in 2016
Table Global Parkinson's Disease Drug Production of Key Manufacturers (2015 and 2016)
Table Global Parkinson's Disease Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Parkinson's Disease Drug Production Share by Manufacturers
Figure 2016 Parkinson's Disease Drug Production Share by Manufacturers
Table Global Parkinson's Disease Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Parkinson's Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Parkinson's Disease Drug Revenue Share by Manufacturers
Table 2016 Global Parkinson's Disease Drug Revenue Share by Manufacturers
Table Global Market Parkinson's Disease Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Parkinson's Disease Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Parkinson's Disease Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Parkinson's Disease Drug Product Type
Figure Parkinson's Disease Drug Market Share of Top 3 Manufacturers
Figure Parkinson's Disease Drug Market Share of Top 5 Manufacturers
Table Global Parkinson's Disease Drug Capacity by Regions (2012-2017)
Figure Global Parkinson's Disease Drug Capacity Market Share by Regions (2012-2017)
Figure Global Parkinson's Disease Drug Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Parkinson's Disease Drug Capacity Market Share by Regions
Table Global Parkinson's Disease Drug Production by Regions (2012-2017)
Figure Global Parkinson's Disease Drug Production and Market Share by Regions (2012-2017)
Figure Global Parkinson's Disease Drug Production Market Share by Regions (2012-2017)
Figure 2015 Global Parkinson's Disease Drug Production Market Share by Regions
Table Global Parkinson's Disease Drug Revenue by Regions (2012-2017)
Table Global Parkinson's Disease Drug Revenue Market Share by Regions (2012-2017)
Table 2015 Global Parkinson's Disease Drug Revenue Market Share by Regions
Table Global Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table China Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table India Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Parkinson's Disease Drug Consumption Market by Regions (2012-2017)
Table Global Parkinson's Disease Drug Consumption Market Share by Regions (2012-2017)
Figure Global Parkinson's Disease Drug Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Parkinson's Disease Drug Consumption Market Share by Regions
Table North America Parkinson's Disease Drug Production, Consumption, Import & Export (2012-2017)
Table Europe Parkinson's Disease Drug Production, Consumption, Import & Export (2012-2017)
Table China Parkinson's Disease Drug Production, Consumption, Import & Export (2012-2017)
Table Japan Parkinson's Disease Drug Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Parkinson's Disease Drug Production, Consumption, Import & Export (2012-2017)
Table India Parkinson's Disease Drug Production, Consumption, Import & Export (2012-2017)
Table Global Parkinson's Disease Drug Production by Type (2012-2017)
Table Global Parkinson's Disease Drug Production Share by Type (2012-2017)
Figure Production Market Share of Parkinson's Disease Drug by Type (2012-2017)
Figure 2015 Production Market Share of Parkinson's Disease Drug by Type
Table Global Parkinson's Disease Drug Revenue by Type (2012-2017)
Table Global Parkinson's Disease Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Parkinson's Disease Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Parkinson's Disease Drug by Type
Table Global Parkinson's Disease Drug Price by Type (2012-2017)
Figure Global Parkinson's Disease Drug Production Growth by Type (2012-2017)
Table Global Parkinson's Disease Drug Consumption by Application (2012-2017)
Table Global Parkinson's Disease Drug Consumption Market Share by Application (2012-2017)
Figure Global Parkinson's Disease Drug Consumption Market Share by Application in 2015
Table Global Parkinson's Disease Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Parkinson's Disease Drug Consumption Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Parkinson's Disease Drug Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Parkinson's Disease Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Parkinson's Disease Drug Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Teva Pharmaceutical Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Parkinson's Disease Drug Market Share (2012-2017)
Table Abbvie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbvie Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbvie Parkinson's Disease Drug Market Share (2012-2017)
Table Akorn Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Akorn Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Akorn Parkinson's Disease Drug Market Share (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Astellas Pharma Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Pharma Parkinson's Disease Drug Market Share (2012-2017)
Table Desitin Arzneimittel Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Desitin Arzneimittel Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Desitin Arzneimittel Parkinson's Disease Drug Market Share (2012-2017)
Table Endo International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Endo International Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Endo International Parkinson's Disease Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Drug
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Parkinson's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2015
Table Major Buyers of Parkinson's Disease Drug
Table Distributors/Traders List
Figure Global Parkinson's Disease Drug Production and Growth Rate Forecast (2017-2021)
Figure Global Parkinson's Disease Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Parkinson's Disease Drug Production Forecast by Regions (2017-2021)
Table Global Parkinson's Disease Drug Consumption Forecast by Regions (2017-2021)
Table Global Parkinson's Disease Drug Production Forecast by Type (2017-2021)
Table Global Parkinson's Disease Drug Consumption Forecast by Application (2017-2021)


More Publications